Recent advances in the management of vasospasm in patients with subarachnoid hemorrhage

Adnan I. Qureshi, Robert Dawson, Michael R. Frankel, Barney Stern

Research output: Contribution to journalArticle

Abstract

BACKGROUND- Cerebral vasospasm in patients with subarachnoid hemorrhage is a major cause of morbidity and mortality. A significant number of patients will develop ischemic complications despite treatment with a calcium channel antagonist and hypervolemic, hypertensive treatment. However, recent advances in prevention and management of vasospasm may improve outcome in patients with subarachnoid hemorrhage. REVIEW SUMMARY- Erythrocyte breakdown products predispose to vasospasm possibly due to activation of the lipooxygenase pathway. Therefore, prevention might include early and effective removal of subarachnoid blood clot by intracisternal administration of thrombolytics. Treatment of symptomatic vasospasm resistant to conventional treatment may require pharmacological or mechanical dilation of involved arteries. Angioplasty is effective in reversing vessel constriction. In addition, intra-arterial infusion of papaverine, a direct-acting smooth muscle relaxant, can reverse vasospasm in arteries inaccessible to angioplasty. CONCLUSIONS- Novel approaches for the prevention and treatment of vasospasm may reduce morbidity and mortality in patients with subarachnoid hemorrhage.

Original languageEnglish (US)
Pages (from-to)53-65
Number of pages13
JournalNeurologist
Volume2
Issue number1
StatePublished - Jan 1 1996
Externally publishedYes

Fingerprint

Subarachnoid Hemorrhage
Angioplasty
Arteries
Morbidity
Therapeutics
Intracranial Vasospasm
Intra Arterial Infusions
Papaverine
Mortality
Calcium Channel Blockers
Constriction
Smooth Muscle
Dilatation
Thrombosis
Erythrocytes
Pharmacology

Keywords

  • Angioplasty
  • Antioxidant
  • Papaverine
  • Thrombolysis
  • Vasospasm

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Recent advances in the management of vasospasm in patients with subarachnoid hemorrhage. / Qureshi, Adnan I.; Dawson, Robert; Frankel, Michael R.; Stern, Barney.

In: Neurologist, Vol. 2, No. 1, 01.01.1996, p. 53-65.

Research output: Contribution to journalArticle

Qureshi, AI, Dawson, R, Frankel, MR & Stern, B 1996, 'Recent advances in the management of vasospasm in patients with subarachnoid hemorrhage', Neurologist, vol. 2, no. 1, pp. 53-65.
Qureshi, Adnan I. ; Dawson, Robert ; Frankel, Michael R. ; Stern, Barney. / Recent advances in the management of vasospasm in patients with subarachnoid hemorrhage. In: Neurologist. 1996 ; Vol. 2, No. 1. pp. 53-65.
@article{2cb8b2c3ed9547eebd4232891e9e05e4,
title = "Recent advances in the management of vasospasm in patients with subarachnoid hemorrhage",
abstract = "BACKGROUND- Cerebral vasospasm in patients with subarachnoid hemorrhage is a major cause of morbidity and mortality. A significant number of patients will develop ischemic complications despite treatment with a calcium channel antagonist and hypervolemic, hypertensive treatment. However, recent advances in prevention and management of vasospasm may improve outcome in patients with subarachnoid hemorrhage. REVIEW SUMMARY- Erythrocyte breakdown products predispose to vasospasm possibly due to activation of the lipooxygenase pathway. Therefore, prevention might include early and effective removal of subarachnoid blood clot by intracisternal administration of thrombolytics. Treatment of symptomatic vasospasm resistant to conventional treatment may require pharmacological or mechanical dilation of involved arteries. Angioplasty is effective in reversing vessel constriction. In addition, intra-arterial infusion of papaverine, a direct-acting smooth muscle relaxant, can reverse vasospasm in arteries inaccessible to angioplasty. CONCLUSIONS- Novel approaches for the prevention and treatment of vasospasm may reduce morbidity and mortality in patients with subarachnoid hemorrhage.",
keywords = "Angioplasty, Antioxidant, Papaverine, Thrombolysis, Vasospasm",
author = "Qureshi, {Adnan I.} and Robert Dawson and Frankel, {Michael R.} and Barney Stern",
year = "1996",
month = "1",
day = "1",
language = "English (US)",
volume = "2",
pages = "53--65",
journal = "Neurologist",
issn = "1074-7931",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Recent advances in the management of vasospasm in patients with subarachnoid hemorrhage

AU - Qureshi, Adnan I.

AU - Dawson, Robert

AU - Frankel, Michael R.

AU - Stern, Barney

PY - 1996/1/1

Y1 - 1996/1/1

N2 - BACKGROUND- Cerebral vasospasm in patients with subarachnoid hemorrhage is a major cause of morbidity and mortality. A significant number of patients will develop ischemic complications despite treatment with a calcium channel antagonist and hypervolemic, hypertensive treatment. However, recent advances in prevention and management of vasospasm may improve outcome in patients with subarachnoid hemorrhage. REVIEW SUMMARY- Erythrocyte breakdown products predispose to vasospasm possibly due to activation of the lipooxygenase pathway. Therefore, prevention might include early and effective removal of subarachnoid blood clot by intracisternal administration of thrombolytics. Treatment of symptomatic vasospasm resistant to conventional treatment may require pharmacological or mechanical dilation of involved arteries. Angioplasty is effective in reversing vessel constriction. In addition, intra-arterial infusion of papaverine, a direct-acting smooth muscle relaxant, can reverse vasospasm in arteries inaccessible to angioplasty. CONCLUSIONS- Novel approaches for the prevention and treatment of vasospasm may reduce morbidity and mortality in patients with subarachnoid hemorrhage.

AB - BACKGROUND- Cerebral vasospasm in patients with subarachnoid hemorrhage is a major cause of morbidity and mortality. A significant number of patients will develop ischemic complications despite treatment with a calcium channel antagonist and hypervolemic, hypertensive treatment. However, recent advances in prevention and management of vasospasm may improve outcome in patients with subarachnoid hemorrhage. REVIEW SUMMARY- Erythrocyte breakdown products predispose to vasospasm possibly due to activation of the lipooxygenase pathway. Therefore, prevention might include early and effective removal of subarachnoid blood clot by intracisternal administration of thrombolytics. Treatment of symptomatic vasospasm resistant to conventional treatment may require pharmacological or mechanical dilation of involved arteries. Angioplasty is effective in reversing vessel constriction. In addition, intra-arterial infusion of papaverine, a direct-acting smooth muscle relaxant, can reverse vasospasm in arteries inaccessible to angioplasty. CONCLUSIONS- Novel approaches for the prevention and treatment of vasospasm may reduce morbidity and mortality in patients with subarachnoid hemorrhage.

KW - Angioplasty

KW - Antioxidant

KW - Papaverine

KW - Thrombolysis

KW - Vasospasm

UR - http://www.scopus.com/inward/record.url?scp=3042862964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042862964&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:3042862964

VL - 2

SP - 53

EP - 65

JO - Neurologist

JF - Neurologist

SN - 1074-7931

IS - 1

ER -